Tag: Tesamorelin
-
Tesamorelin: Mechanism, Benefits & Research Evidence
Class & Mechanism Tesamorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), specifically a 29-amino acid fragment of the natural…
-
If Tesamorelin only modestly reduces visceral adipose tissue (~15%) in its approved HIV-lipodystrophy population, why do off-label users expect dramatic body recomposition — and what cognitive bias is doing the lifting?
Off-label tesamorelin hype is powered by the availability cascade that substitutes the dramatic 20 % fat-loss figure from true GH studies for the peptid
-
If Tesamorelin produces less IGF-1 elevation than equivalent GH-induced fat loss would predict, what alternative pathway (lipolysis-direct, central) is doing the work — and does that mean GH-axis side-effect concerns are overstated?
Tesamorelin strips visceral fat primarily through direct adipocyte lipolysis and possibly central neuronal signaling, not through robust IGF-1 elevation